Bill > HR4055

This bill aims to amend Medicare (Title XVIII of the Social Security Act) to provide coverage and payment for treatments specifically addressing dialysis-related amyloidosis, a serious medical condition that can occur in patients receiving long-term dialysis. The bill would add a new category of medical services to Medicare coverage, defining "treatments for dialysis-related amyloidosis" as any FDA-approved item or service provided in a dialysis facility (either freestanding or hospital-based) that treats this condition, along with necessary supplies and supporting services. Importantly, these treatments would be excluded from the standard renal dialysis services category and would be reimbursed separately at 100% of reasonable charges, rather than being bundled into existing prospective payment amounts or comprehensive fees. This means patients undergoing treatment for dialysis-related amyloidosis would receive more comprehensive and potentially more flexible coverage for their specialized medical needs. The amendments would take effect immediately upon the Act's enactment, providing timely support for patients dealing with this specific dialysis-related health complication.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/4055/all-info